NCT06484062
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06484062
Title Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Yale University RECRUITING New Haven Connecticut 06520 United States Details
Emory University Hospital/Winship Cancer Institute RECRUITING Atlanta Georgia 30322 United States Details
University of Chicago Comprehensive Cancer Center RECRUITING Chicago Illinois 60637 United States Details
University of Maryland/Greenebaum Cancer Center RECRUITING Baltimore Maryland 21201 United States Details
Dana-Farber Cancer Institute RECRUITING Boston Massachusetts 02215 United States Details
Rutgers Cancer Institute of New Jersey RECRUITING New Brunswick New Jersey 08903 United States Details
Memorial Sloan Kettering Cancer Center RECRUITING New York New York 10065 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field